Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

The glucocorticoid receptor helps protect skin from tumors and other issues.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

Calretinin can help identify certain skin structures and tumors.

HPV does not cause aggressive cancer in RDEB patients.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Erlotinib can cause hair loss as a side effect.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.

The HR protein helps hair grow by blocking a hair growth inhibitor, aiding in hair follicle regeneration.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

The BUZZ gene is important for root hair growth and overall root structure in the plant Brachypodium distachyon.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

Key genes and RNA networks regulate hair growth and follicle density in Rex rabbits.

Mutations in certain receptors can cause diseases and offer new treatment options.

The research found that specific stem cells maintain skin gland openings and that disrupting their activity can cause blockages or early cancer signs, indicating a need for targeted treatments.